Treatment with EVs secreted by adipose tissue-derived MSCs (AD-MSCs-ex) in T1D mice significantly increased the levels of IL-4, IL-10, and transforming growth factor β, while decreasing IL-17 and IFN-γ levels. The gene discussed is IL17A; the disease is type 1 diabetes mellitus.